Esteve, a Spanish pharmaceutical company, completed the acquisition of Riemser, a German pharma firm from Ardian. Financial terms were not disclosed. "This acquisition is a meaningful contribution to our strategic path towards making Esteve much more of an international proprietary, specialty pharma company. Riemser contributes both knowledge and experience in the European hospital market, in addition to pharmaceutical activity in four of the major European markets - Germany, United Kingdom, France, and Spain. Riemser's presence and facilities in these geographically important markets provide significant growth potential for Esteve and we will, as a combined entity with Riemser, continue our quest for further expansion," Staffan Schüberg, ESTEVE CEO.